Related Experiment Videos
[A 5-year-old patient with allergic diseases responsive to stellate ganglion block]
K Kageshima1, B Wakasugi, H Hajiri
1Department of Anesthesiology, Jikei University School of Medicine, Tokyo.
Insights
Stellate ganglion block (SGB) therapy effectively treated a child with multiple allergic conditions. This nerve block may benefit pediatric patients with drug-resistant allergies.
Area of Science:
- Immunology
- Neurology
- Pediatrics
Background:
- Allergic diseases like rhinitis, sinusitis, and dermatitis often present complex management challenges.
- Conventional treatments including pharmacotherapy and dietary modifications may not always yield satisfactory results.
- Pediatric allergic conditions require safe and effective therapeutic options.
Observation:
- A 5-year-old boy with a history of allergic rhinitis, chronic sinusitis, atopic dermatitis, and frequent common colds was evaluated.
- The patient exhibited resistance to standard allergy treatments.
- Stellate ganglion block (SGB) was administered as a potential therapeutic intervention.
Findings:
- The patient demonstrated a significant positive response to stellate ganglion block (SGB) therapy.
- SGB treatment was exceptionally effective in managing the patient's constellation of allergic symptoms.
- The observed efficacy suggests SGB as a viable treatment modality.
Implications:
- Stellate ganglion block (SGB) therapy shows promise for allergic diseases refractory to conventional treatments.
- The findings support the consideration of SGB for pediatric patients with difficult-to-manage allergic conditions.
- Nerve block therapies, including SGB, may have expanded indications in pediatric populations.
Abstract:
We examined a 5-year-old boy with allergic rhinitis, chronic sinusitis, atopic dermatitis, and tendency to suffer common cold, who responded to stellate ganglion block (SGB). SGB therapy was extremely effective for this patient. The result suggests that SGB therapy should be performed on patients with allergic diseases resistant to drug and diet therapy. Furthermore, the indication for nerve block therapy, such as SGB, may be extended even to pediatric patients.